Bevacizab 400mg Injection is a targeted therapy medication used in the treatment of various types of cancer. Its active ingredient, Bevacizumab, is a monoclonal antibody that works by inhibiting vascular endothelial growth factor (VEGF). VEGF is a protein that stimulates the growth of new blood vessels, which tumors need to grow and spread. By blocking VEGF, Bevacizab helps to slow down or stop tumor growth and can prevent the formation of new blood vessels in the tumor.
Bevacizab 400mg Injection is indicated for the treatment of metastatic colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, and persistent, recurrent, or metastatic cervical cancer. The dosage and duration of treatment are determined by the prescribing physician based on the specific type and stage of cancer, as well as the patient’s overall health.
Common side effects may include high blood pressure, nosebleeds, protein in the urine, and fatigue. Serious side effects can occur, so it is important to discuss any concerns with your healthcare provider. Bevacizab 400mg Injection should be stored at room temperature and protected from light. It is crucial to administer this medication under the supervision of a qualified healthcare professional.
